Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapynews2026-04-24T14:00:16+00:00April 24th, 2026|Endpoints News|
Medicare indefinitely delays pilot plan to cover weight loss drugsnews2026-04-21T20:21:55+00:00April 21st, 2026|Endpoints News|
Kailera IPO interview: CEO Renaud talks biotech market, China and obesity pipelinenews2026-04-17T16:06:25+00:00April 17th, 2026|Endpoints News|
Kailera raises $625M IPO in biotech recordnews2026-04-17T11:28:56+00:00April 17th, 2026|Endpoints News|
Lilly’s tirzepatide sheds lean muscle harder than Novo’s semaglutide, study suggestsnews2026-04-17T11:15:32+00:00April 17th, 2026|Endpoints News|
